# data[].attributes.body
2003: Elizabeth Holmes, who  was a young Stanford science major, established Theranos in order to revolutionize blood testing.

# data[].attributes.body
In 2003, a college student named Elizabeth Holmes started a company, Theranos, for blood testing.

# data[].attributes.body
2004: Theranos raised $6.9 million in early funding gaining a $30 million valuation.

# data[].attributes.body
2004: In the beginning, Theranos earned $30 million by mobilizing $6.9 million.

# data[].attributes.body
2007: The company's valuation hit $197 million after it raised another $43.2 million in early-round funding.

# data[].attributes.body
2007: The firm drew $43.2 million in the beginning, and then it reached to the value of $197 million.

# data[].attributes.body
2010: After further rounds of funding, Theranos was valued at $1 billion.

# data[].attributes.body
2010 Theranos was rated at  $1 billion with additional funding.

# data[].attributes.body
2013: After a decade working "in the dark," Holmes introduced Theranos to the world via press appearances and unveiled a website.

# data[].attributes.body
2013: Holmes informed the world about her company through public media after ten years anonymous time.

# data[].attributes.body
2014: With over $400 million in funding, Theranos was valued at nearly $9 billion. Holmes effectively became a multi-billionaire thanks to her 50% stake.

# data[].attributes.body
2014: Theranos gathered  more than $400 million in funding. Since she had over 50% stake of the company's worth,  Holmes was ranked as one of the world's richest people, worth $9 billion.

# data[].attributes.body
December 2014: Despite her company's hefty valuation, Holmes remained tight-lipped on how exactly Theranos’s technology worked. It turned out that the technology had never been submitted for peer review in medical journals.

# data[].attributes.body
December 2014. Holmes kept in silence about the technological achievement, even though the firm had gotten a lot of funding.

# data[].attributes.body
July 8, 2015: Capital BlueCross, a Pennsylvania insurer with 725,000 customers, chose Theranos as its preferred lab work provider. Theranos was valued at $10 billion.

# data[].attributes.body
July 8, 2015: Theranos was selected as the best lab work supplier by capital BlueCross, an insurance company in Pennsylvania. Its company had 725,000 clients. Theranos was rated at $10 billion.

# data[].attributes.body
October 15, 2015: The Wall Street Journal ran a scathing article criticizing Theranos.

Holmes appeared on "Mad Money" and other media outlets to do damage control. She was “shocked” by the Wall Street Journal article and claimed that Theranos supplied over 1,000 pages of documentation to refute the allegations. The Wall Street Journal stood by its reporting.

# data[].attributes.body
October 15, 2015: Holmes did a lot of damage control by showing up on media like "Mad Money". However, the Wall Street Journal's evidence indicated that the Theranos have well prepared for the allegation from public. The Wall Street Journal endorsed its article.

# data[].attributes.body
October 16, 2015: A follow-up article in the Wall Street Journal stated that Theranos was forced to suspend the use of its unapproved nanotainer for all but one type of blood test.

# data[].attributes.body
Oct 16, 2015 Theranos had no choice but to utilize its nanotainer for the only one type of blood test. That was what the Wall Street Journal pointed out in the series of articles.

# data[].attributes.body
October 27, 2015: The FDA released two partially-redacted Form 483 reports from an ongoing investigation into Theranos.

# data[].attributes.body
October 27, 2015: In the result of inspection of Theranos, the FDA published the Form 483 reports which is partially re-edited.

# data[].attributes.body
October 28, 2015: Fortune reported that Theranos had sought to raise an additional $200 million in Series C-3 funding just days before the initial Wall Street Journal article was published.

# data[].attributes.body
October 28, 2015: According to Fortune,  Theranos requested to add $200 million to Series C-3 funding, just days before the first report published by Wall Street Journal.

# data[].attributes.body
November 10, 2015: A $350 million deal with Safeway fizzled out after Theranos failed to meet key deadlines for rollouts and Safeway executives questioned the validity of the test results.

# data[].attributes.body
Because  of Theranos‘ failure to provide the test results in time, the transaction between Theranos and Safeway terminated. And the manager of Safeway began to query the effectiveness of its test results.

# data[].attributes.body
December 27, 2015: The Wall Street Journal ran another article alleging management ineptitude at Theranos and test rigging to produce better results for its Edison machines.

# data[].attributes.body
Dec 27, 2015: According to The Wall Street Journal, Theranos allegedly ran a  rampant management  and manipulated test  for better results for its Edison machines.

# data[].attributes.body
January 27, 2016: The Centers for Medicare & Medicaid Services (CMS) releases its damming report on Theranos' California-based lab.

# data[].attributes.body
Jan 27, 2016: The document about the Theranos' laboratory was published by the Centers for Medicare & Medicaid Services (CMS) .

# data[].attributes.body
January 28, 2016: Following the CMS report, Walgreens Boots Alliance Inc. (WBA) decided to temporarily close the Theranos Wellness Center in its Palo Alto store and suspend its use of Theranos's Newark, Calif. lab.

# data[].attributes.body
January 28, 2016: The CMS finding resulted in that WBA made a decision of shutting the Theranos Wellness Center in its Palo Alto shop down and ceasing it's avail of Therano's Newwark, Calif.lab.

# data[].attributes.body
May 1, 2017: Theranos settled a lawsuit with Partner Fund Management, one of its largest investors, after the hedge fund accused the company of securities fraud. Theranos had previously settled proceedings with the Centers for Medicare & Medicaid Services and the Arizona Attorney General.

# data[].attributes.body
May 1, 2017: Theranos have engaged in many lawsuit with the its investors, medical service center and attorney general.

# data[].attributes.body
March 14, 2018: The SEC charged Theranos, its founder and CEO Elizabeth Holmes, and its former President Ramesh "Sunny" Balwani with massive fraud.

# data[].attributes.body
March 14, 2018 Elizabeth Holmes, the founder and CEO of Theranos, and Ramesh "Sunny" Balwani, its former President, were charged for massive fraud by the SEC.

# data[].attributes.body
June 15, 2018: A federal grand jury indicted both Holmes and Balwani on nine counts of wire fraud and two counts of conspiracy to commit wire fraud.

# data[].attributes.body
June 15, 2018: Holmes and Balwani were charged with nine wired fraud and two collusions of assigning wire fraud by a federal grand jury.

# data[].attributes.body
June 15, 2018: The press release from the U.S. Attorney's Office stated that in order to promote Theranos, both Holmes and Balwani "engaged in a multi-million dollar scheme to defraud investors and a separate scheme to defraud doctors and patients."

Holmes had stepped down as Theranos CEO earlier in the day although she continues to be the chair of the company's board.

# data[].attributes.body
The press release from the U.S. Attorney's Office mentioned that not only Holmes but also Balwani "engaged in a multi-million dollar scheme to defraud investors and a separate scheme to defraud doctors and patients." Its purpose is to advertise Theranos.